ACCENT	Adjuvant Colon Cancer End Points
CRC	Colorectal cancer
cfDNA	Cell-free DNA
ccfDNA	Circulating cfDNA
CCS	Colon cancer subtyping
cfNA	Cell-free nucleic acid
CMS	Consensus molecular subtyping
CTC	Circulating tumor cell
ctDNA	Circulating tumor DNA
dPCR	Digital PCR
ddPCR	Droplet dPCR
DNA	Deoxyribonucleic acid
FDA	Food and drug administration
FFPE	Formalin-fixed paraffin-embedded
GI	Genomic instability
iFOBT	Immunochemical fecal occult blood test
IHC	Immunohistochemistry
ITH	Intratumoral heterogeneity
LS	Lynch syndrome
mCRC	Metastatic CRC
MLH	MutL homolog
MMR	Mismatch repair
MMR-D	Mismatch deficiency
MSH	MutS homolog
MSI	Microsatellite instability
MSI-H	MSI-high
MSI-L	MSI-low
MSS	Microsatellite stable
NGS	Next-generation sequencing
PCR	Polymerase chain reaction
PMS	Postmeiotic segregation
RNA	Ribonucleic acid
TMB	Tumor mutation burden.